Article
|
Open Access
Featured
-
-
Article
| Open Access
A multinational Delphi consensus to end the COVID-19 public health threat
A diverse, multidisciplinary panel of 386 experts in COVID-19 response from 112 countries provides health and social policy actions to address inadequacies in the pandemic response and help to bring this public health threat to an end.
- Jeffrey V. Lazarus
- , Diana Romero
- & Anne Øvrehus
-
Article |
Factors associated with COVID-19-related death using OpenSAFELY
OpenSAFELY, a new health analytics platform that includes data from over 17 million adult NHS patients in England, is used to examine factors associated with COVID-19-related death.
- Elizabeth J. Williamson
- , Alex J. Walker
- & Ben Goldacre
-
Article |
Effect of non-pharmaceutical interventions to contain COVID-19 in China
A model of the effects of different non-pharmaceutical interventions on the spread of COVID-19 in China suggests that a strategy involving the rapid implementation of a combination of interventions is most effective.
- Shengjie Lai
- , Nick W. Ruktanonchai
- & Andrew J. Tatem
-
Outlook |
Public health: The politics of antibiotics
Policy-makers and medical experts need to think globally if we are to prevent an antibiotic 'tragedy of the commons'.
- Megan Cully
-
Spotlight |
Spotlight on Immunology
-
Letter |
The global distribution and burden of dengue
The public health burden of dengue is unknown; here cartographic approaches are used to provide insight into the global, regional and national burden of dengue, with the finding that the global number of infections per year is around 390 million, more than three times the estimate of the World Health Organization.
- Samir Bhatt
- , Peter W. Gething
- & Simon I. Hay
-
Editorial |
A burden weighed
Despite some shortcomings, a global study of health metrics should be applauded.
-
Editorial |
Misguided cancer goal
An influential US advocacy group has set a deadline to beat breast cancer by 2020. But it puts public trust at risk by promising an objective that science cannot yet deliver.
-
News |
Fresh start for global disease fund
But shake-up raises doubts over the future of a major malaria-control programme.
- Declan Butler
-
Editorial |
Life after death
Restricting access to US death records could have serious consequences for long-term health studies. Government agencies should rethink their decision.
-
News |
Cancer institute tackles sloppy data
Funder demands better evidence for biomarkers in clinical trials.
- Monya Baker
-
News |
India moves to tackle antibiotic resistance
Drug regulator aims to restrict over-the-counter sales.
- Erica Westly
-
News |
India shakes up rules on clinical trials
But compensation scheme draws fire for raising costs for academic researchers.
- Daniel Cressey
-
News |
Mexico chalks up success in health-care reforms
Near-universal coverage results from science-informed changes.
- Erik Vance
-
Comment |
Bring order to unregulated health markets
Uncontrolled medical treatment in Asia and Africa costs lives and money. David Peters and Gerald Bloom call for governments, firms and citizen groups to get involved.
- David H. Peters
- & Gerald Bloom
-
News |
Health law worries hospitals
US academic centres fear they will lose out as upheld Affordable Care Act cuts payments.
- Meredith Wadman
-
Editorial |
A war not yet won
The eradication of polio is within reach, but it is too early for self-congratulation.
-
News |
Polio’s last stand
As the global eradication effort ramps up, funding shortfalls threaten the programme’s gains in Africa and Asia.
- Ewen Callaway
-
News |
US government sets out Alzheimer’s plan
Health-agency budget windfall includes funding for two promising clinical trials.
- Meredith Wadman
-
News |
Child-study turmoil leaves bitter taste
Frustration mounts as ambitious US project is scaled back.
- Meredith Wadman
-
News |
Malaria surge feared
The WHO releases action plan to tackle the spread of insecticide-resistant mosquitoes.
- Amy Maxmen
-
Comment |
Strengthen and stabilize the FDA
The US Food and Drug Administration needs to be more independent, says Daniel Carpenter.
- Daniel Carpenter
-
-
Comment |
Regulate alcohol for global health
The World Health Organization is the only body that can promote health through the use of international law. It should make alcohol its next target, says Devi Sridhar.
- Devi Sridhar
-
Comment |
Bring clinical standards to human-genetics research
Study protocols need to be rigorous, because more than science is at stake. Sometimes participants' lives depend on the results, writes Gholson J. Lyon.
- Gholson J. Lyon
-
News |
Minnesota starts to destroy stored blood spots
Court ruling that the state must get consent to store samples from newborn screening could hinder biomedical research.
- Meredith Wadman
-
-
Correspondence |
Pause on avian flu transmission studies
- Ron A. M. Fouchier
- , Adolfo García-Sastre
- & Yoshihiro Kawaoka
-
News |
Fines expose failings in policing of Indian drug trials
Paltry penalties for doctors involved in unethical clinical trials spark controversial reforms.
- M Sreelata
-
News Q&A |
Bird flu and the future of biosecurity
Plans for restricted access to bird flu papers expected 'within the next few weeks'.
- Heidi Ledford
-
News |
Rules tighten on use of antibiotics on farms
Clampdown aims to stop spread of drug-resistant microbes.
- Natasha Gilbert
-
Editorial |
The morning after
President Barack Obama's stance on an emergency contraceptive betrays his promised principles of scientific integrity and sets a troubling precedent for political interference in 'inconvenient' science.
-
Outlook |
Patents: Protecting China's national treasure
Applying modern intellectual property standards to ancient medicines.
- Jessie Jiang
-
News |
Fears grow over lab-bred flu
Scientists call for stricter biosafety measures for dangerous avian-influenza variants.
- Declan Butler
-
-
Comment |
Preventing hunger: Sustainability not aid
Fifty years after its founding, UN World Food Programme head Josette Sheeran explains why the agency is now focusing on projects that help communities weather food crises.
- Josette Sheeran
-
-
News |
Fukushima 'hot spots' raise radiation fears
But experts see little threat from patches of heightened radioactivity.
- Geoff Brumfiel
-
News |
France toughens conflict rules
Law demands greater transparency for health experts.
- Declan Butler
-
World View |
The voice of science: let's agree to disagree
Consensus reports are the bedrock of science-based policy-making. But disagreement and arguments are more useful, says Daniel Sarewitz.
- Daniel Sarewitz
-
News Feature |
Science publishing: The trouble with retractions
A surge in withdrawn papers is highlighting weaknesses in the system for handling them.
- Richard Van Noorden
-
News |
Future of Chernobyl health studies in doubt
European Commission unlikely to fund lifetime studies of those affected by fallout.
- Declan Butler
-
News Feature |
A multi-billion dollar injection: Stimulus—response
The United States' 2009 financial stimulus bill has provided research with breathing space, rather than the sharp shot in the arm that many anticipated.
- Colin Macilwain
-
News |
Draft guidelines for nanomedicine unveiled
With hundreds of nanoproducts currently being tested in humans, recommendations aim to safeguard trial participants.
- Jessica Marshall
-
News Feature |
Translational research: 4 ways to fix the clinical trial
Clinical trials are crumbling under modern economic and scientific pressures. Nature looks at ways they might be saved.
- Heidi Ledford
-
News |
Germany learns from E. coli outbreak
Government plans to upgrade its disease-reporting processes.
- Marian Turner
-
News |
Microbe outbreak panics Europe
Spread of rare Escherichia coli strain raises questions over surveillance of infectious diseases.
- Marian Turner
-
News |
Cash cure for the AIDS epidemic?
South African researchers are testing whether financial incentives can stop HIV infection in teenagers.
- Priya Shetty
-
News |
Neuroscientists unite for 'Moon shot'
Effort aims to bring together philanthropies with common interest in brain diseases.
- Heidi Ledford
Financial incentives for vaccination do not have negative unintended consequences